Soleus Capital Master Fund, L.P. - 02 Feb 2026 SCHEDULE 13G Report for Context Therapeutics Inc. Common Stock, par value $0.001 per share (CNTX)

Filing Manager
Soleus Capital Master Fund, L.P.
Reporting Manager
Soleus Capital Master Fund, L.P.
Security
Context Therapeutics Inc. Common Stock, par value $0.001 per share
Symbol
CNTX
Shares outstanding
91,853,808 shares
Disclosed Ownership
4,776,398 shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
03 Feb 2026, 16:41:54 UTC
Date of event
02 Feb 2026
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Soleus Capital Master Fund, L.P. 5.2% 4,776,398 0 4,776,398 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital, LLC 5.2% 4,776,398 0 4,776,398 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Group, LLC 5.2% 4,776,398 0 4,776,398 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Management, L.P. 5.2% 4,776,398 0 4,776,398 /s/ Guy Levy Guy Levy/Managing Member
Soleus GP, LLC 5.2% 4,776,398 0 4,776,398 /s/ Guy Levy Guy Levy/Managing Member
Guy Levy 5.2% 4,776,398 0 4,776,398 /s/ Guy Levy Guy Levy/Managing Member